Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 3287
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT00907192 | Self Reported Deviations From Opioid Analgesic Prescription | ||
| NCT00707434 | Continuous Glucose Monitoring in Critically Ill | ||
| NCT01856114 | Fentanyl Buccal Tablets for Exercise Induced Breakthrough Dyspnea | ||
| NCT07377006 | Decision Support Tool to Enhance Germline Genetic Testing for Patients With Prostate Cancer | ||
| NCT00472849 | Oxaliplatin, Fludarabine, Cytarabine, and Rituximab in Patients With Richter's Transformation and Leukemias | ||
| NCT05634577 | A Phase II Study to Evaluate the Efficacy and Safety of Pembrolizumab in Combination With Mitotane in Patients With Advanced Adrenocortical Carcinoma | ||
| NCT05755984 | 3D Printed Breast Models in the Surgical Management of Breast Cancer | ||
| NCT07408310 | Trial of Spiritual Care Interventions for Patients With Cancer | ||
| NCT01833520 | Phase I Dose Escalation of Monthly Intravenous Ra-223 Dichloride in Osteosarcoma | ||
| NCT02532192 | A Phase Ib Study of Belinostat With RDHAP Chemotherapy (Dexamethasone, Cytarabine, Cisplatinum) in Adults With Relapsed or Refractory Diffuse Large B-cell Lymphoma | ||
| NCT02263014 | Psychosocial Outcomes and Contralateral Prophylactic Mastectomy (CPM) | ||
| NCT05329506 | Attitudes and Believes About Vaccinations in a Supportive Care Patient Population | ||
| NCT00777192 | Longitudinal Study of Symptoms in Colorectal Cancer | ||
| NCT04965714 | Nivolumab and ADI-PEG 20 Before Surgery for the Treatment of Resectable Liver Cancer | ||
| NCT03391869 | Nivolumab and Ipilimumab With or Without Local Consolidation Therapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer | ||
| NCT00850941 | Radiation Therapy for Rising Prostate Specific Antigen (PSA) Post-prostatectomy | ||
| NCT00813254 | Cost Utility Analysis in Recurrent Ovarian Cancer | ||
| NCT02532257 | Ibrutinib in Combination With Rituximab and Lenalidomide in Treating Patients With Previously Untreated, Stage II-IV Follicular Lymphoma or Marginal Zone Lymphoma | ||
| NCT01844557 | Testing Accountability in Patient Adherence | ||
| NCT02738606 | Liver Surgery and Chemotherapy in Treating Patients With Colorectal Cancer With Liver Metastases That Can Be Removed by Surgery and Lung Metastases That Cannot Be Removed by Surgery | ||
| NCT01460498 | Azacitidine (AZA) in Minimal Residual Disease (MRD) Chronic Myeloid Leukemia (CML) | ||
| NCT00502125 | In Vivo Confocal Imaging of Oral Mucosa | ||
| NCT00833625 | FDG-PET-CT and Biomarkers in Esophageal Cancer | ||
| NCT00916578 | Xeloda (Capecitabine) and External Beam Radiation | ||
| NCT03491176 | Magnetic Resonance (MR) Imaging & Blood Biomarkers for Head and Neck Cancer | ||
| NCT00632515 | Screening for Familial Colorectal Cancer (CRC) Patients | ||
| NCT01184534 | Multimedia Patient Education | ||
| NCT05474352 | Use of Water Warming/Cooling Garment to Maintain a Constant Intraoperative Core Target Temperature in Patients Undergoing Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy (HIPEC): A Proof-of-Concept Study | ||
| NCT04940299 | Tocilizumab, Ipilimumab, and Nivolumab for the Treatment of Advanced Melanoma, Non-Small Cell Lung Cancer, or Urothelial Carcinoma | ||
| NCT03770416 | Nivolumab and Ibrutinib in Treating Patients With Relapsed or Refractory Central Nervous System Lymphoma | ||
| NCT04487106 | Azacitidine, Venetoclax, and Trametinib for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia or Higher-Risk Myelodysplastic Syndrome | ||
| NCT07226804 | Nanosecond Pulsed Field Ablation in the Management of Benign Thyroid Nodules | ||
| NCT00502749 | Exercise Program for Adolescents and Young Adults With Cancer | ||
| NCT02152943 | Everolimus, Letrozole and Trastuzumab in HR- and HER2/Neu-positive Patients | ||
| NCT01157533 | Utility of Vancomycin Loading: A Pharmacokinetic Analysis in Critically Ill Patients | ||
| NCT05029752 | Feasibility of Digital Thermal Monitoring to Assess Endothelium-Dependent Vasodilation in Patients Undergoing Hematopoietic Cell Transplantation (HCT) | ||
| NCT06040255 | Focal Cerebral Arteriopathy Steroid Trial | ||
| NCT00422591 | Standard Idarubicin and Cytarabine for the Treatment of Acute Myeloid Leukemia (AML) | ||
| NCT01031498 | Palonosetron Versus Ondansetron for the Prevention of Nausea and Vomiting | ||
| NCT04407247 | Infliximab or Vedolizumab in Treating Immune Checkpoint Inhibitor-Related Colitis in Patients With Genitourinary Cancer or Melanoma | ||
| NCT05467085 | Imaging-Guided Low Intensity Focused Ultrasound (LIFU) | ||
| NCT07076485 | Shortening Adjuvant Photon and Proton Irradiation (SAPPHIRe-II): A 4 Cohort, Randomized, Phase II Multi-center Trial Evaluating Shorter Schedules of Adjuvant Regional Nodal Irradiation Among Women and Men With Node-positive and High-risk Node-negative Invasive Breast Cancer | ||
| NCT05668949 | Phase I/II Open Label Study Evaluating the Safety and Efficacy of Combining STAT3 Inhibition (TTI-101) With Anti-PD-1 Therapy (Pembrolizumab) in Patients With Recurrent or Metastatic (RM) Head and Neck Squamous Cell Carcinoma (HNSCC) | ||
| NCT00005991 | Gemcitabine and Liposomal Doxorubicin in Treating Women With Metastatic Breast Cancer | ||
| NCT00504582 | Fibrin Melanoma Axillary Node Study in Patients With Melanoma | ||
| NCT04874480 | Tegavivint for the Treatment of Relapsed or Refractory Leukemia | ||
| NCT06337097 | STRICT - Surveillance With TRoponin During Immune Checkpoint Therapy | ||
| NCT06261060 | Low-Dose Sirolimus to Increase Hematopoietic Function in Patients With RUNX1 Familial Platelet Disorder | ||
| NCT00071396 | Campath-1H Plus Rituximab for CD52- and CD20- Positive Refractory or Relapsed Chronic Lymphoid Disorders | ||
| NCT04675710 | Pembrolizumab, Dabrafenib, and Trametinib Before Surgery for the Treatment of BRAF-Mutated Anaplastic Thyroid Cancer |
